TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.
主要优势: Teosyal RHA 1
- Corrects superficial fine wrinkles, skin cracks and depressions
- Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
- Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
- Degree of cross-linking below 5%, with residual BDDE below 1 ppm
- Mean molecular weight above 1 million Dalton, of non-animal origin
- Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
- Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
- Estimated duration of at least 12 months
适应症与专业用途
主要适应症
- Superficial fine wrinkles, skin cracks and depressions
- Enhancement of skin quality and correction of withered skin marked by signs of ageing
专业用途
TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.
治疗部位
- Perioral region: perioral rhytids, lips including the philtrum, oral commissures
- Upper face: forehead lines
- Periorbital region: crow's feet, tear trough, eyebrows
- Midface: smiling lines and accordion lines
- Neck lines
- Face, neck and décolleté, for skin quality
适用患者
For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.
作用原理: Teosyal RHA 1
TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 TEOSYAL 产品,来自经过严格审核的供应商,具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地,以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果,并提供专属售后支持,让您安心无忧。
常见问题
How does TEOSYAL RHA 1 differ from the rest of the RHA line?
Concentration and placement. Teosyal RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. Teosyal RHA 2 and Teosyal RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and Teosyal RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.
How long does TEOSYAL RHA 1 last?
The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
更多产品: Teoxane
TEOXANE 产品
查看全部 18诊所替代选择
继续浏览
TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.
主要优势: Teosyal RHA 1
- Corrects superficial fine wrinkles, skin cracks and depressions
- Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
- Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
- Degree of cross-linking below 5%, with residual BDDE below 1 ppm
- Mean molecular weight above 1 million Dalton, of non-animal origin
- Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
- Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
- Estimated duration of at least 12 months
适应症与专业用途
主要适应症
- Superficial fine wrinkles, skin cracks and depressions
- Enhancement of skin quality and correction of withered skin marked by signs of ageing
专业用途
TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.
治疗部位
- Perioral region: perioral rhytids, lips including the philtrum, oral commissures
- Upper face: forehead lines
- Periorbital region: crow's feet, tear trough, eyebrows
- Midface: smiling lines and accordion lines
- Neck lines
- Face, neck and décolleté, for skin quality
适用患者
For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.
作用原理: Teosyal RHA 1
TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 TEOSYAL 产品,具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does TEOSYAL RHA 1 differ from the rest of the RHA line?
Concentration and placement. Teosyal RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. Teosyal RHA 2 and Teosyal RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and Teosyal RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.
How long does TEOSYAL RHA 1 last?
The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.